Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • UK mortgage rates rise at fastest pace in a decade
    • Cern scientists restart hunt for answers to mysteries of universe
    • ‘It’s hard to leave’: Moscow’s fresh wave of missile attacks rekindle Kyivans’ fear
    • UK science minister in dispute with Treasury over post-Brexit funding
    • Eurozone inflation hits record 8.6% in June
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • When it comes to inflation, it’s not déjà vu all over again
    • Chinese hackers kept up hiring drive despite FBI indictment
    • US government bonds rally after factory data heighten recession fears
    • Google closes data loophole amid privacy fears over abortion ruling
    • Central banks look to China’s renminbi to diversify foreign currency reserves
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Klarna valuation crashes to $6.5bn from $46bn
    • Ryanair chief warns fares will rise for 5 years because flying is ‘too cheap’
    • Boots left in limbo as bids fail to emerge
    • Vatican suffers £100mn-plus loss on Knightsbridge office sale
    • Covid could not sink cruise lines — but they now face an iceberg of debt
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • Klarna valuation crashes to $6.5bn from $46bn
    • US government bonds rally after factory data heighten recession fears
    • A soft landing is becoming a distant dream
    • The looming risks in private equity returns
    • Live news updates from July 1: Crypto in focus as FTX buys BlockFi and Voyager Digital halts trading, Eurozone inflation hits record
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • The end of the frictionless life
    • When it comes to inflation, it’s not déjà vu all over again
    • A soft landing is becoming a distant dream
    • Mukesh Ambani: India’s top businessman starts succession planning
    • Warning: Britain’s new bill of rights is a cynical power grab
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • How can I move from being a specialist police detective to financial services?
    • What’s a good (and bad) way to leave your job?
    • If you want to be more likeable, try showing more stress
    • ‘Exactly how much virtue do you really want to signal?’
    • JSR’s Eric Johnson: ‘I encourage people to tell me exactly how they think’
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Life on the idyllic Swedish island where WW3 could start
    • Serhii Plokhy: Putin’s imperialist narrative ‘is being crushed’
    • The end of the frictionless life
    • Have we had enough of the nanny employer?
    • Swimsuits to make a splash in 
  • HTSI
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Vectura Group PLC

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Thursday, 16 September, 2021
    Philip Morris International Inc
    Tobacco group Philip Morris wins control of inhaler company Vectura

    Cigarette maker secures majority of shares in UK-based medical device manufacturer

  • Friday, 20 August, 2021
    Mergers & Acquisitions
    Vectura investors under the microscope as Philip Morris hunts victory

    Shareholders in UK inhaler maker will have final say in a takeover battle that has divided opinion

  • Wednesday, 18 August, 2021
    Brooke Masters
    Moral outrage over Philip Morris’s bid for Vectura is misplaced

    We must allow companies to reinvent themselves and address the problems they helped create

  • Friday, 13 August, 2021
    FT News Briefing podcast9 min listen
    Airbnb up on travel recovery; financial technology grows in Africa

    Short-term rental provider reports strong revenue growth, but warns on spread of Covid variants

  • Thursday, 12 August, 2021
    Mergers & Acquisitions
    Tobacco group PMI wins support of Vectura’s board for £1bn takeover

    Inhaler maker draws criticism from health charity for ‘absurd’ deal

  • Wednesday, 11 August, 2021
    FT News Briefing podcast10 min listen
    Inflation expected to level off, the bidding war for Vectura

    Forecasts show the rapid pace of US consumer price increases is expected to cool

  • Tuesday, 10 August, 2021
    Carlyle steps back from Vectura bidding war with Philip Morris

    Private equity group says lower offer for UK inhaler maker is final, calling off five-day auction

  • Monday, 9 August, 2021
    Helen Thomas
    Vectura auction doesn’t let its board off stakeholder hook

    UK inhaler group has bungled handling competing interests from cigarette-maker Philip Morris and Carlyle

  • Monday, 9 August, 2021
    Philip Morris and Carlyle face auction in battle for inhaler group

    UK regulator to oversee five days of bidding for Vectura by cigarette producer and private equity firm

  • Sunday, 8 August, 2021
    Private equity
    Philip Morris raises offer in bidding war for UK inhaler group Vectura

    Tobacco group lifts bid above £1bn in battle with Carlyle as private equity targets British businesses

  • Friday, 6 August, 2021
    Carlyle increases offer in bidding war for UK inhaler-maker Vectura

    Group welcomes bid that threatens to scupper rival deal with Philip Morris International

  • Tuesday, 20 July, 2021
    Helen Thomas
    When corporate purpose goes up in smoke

    Philip Morris International’s deal to buy inhaler company Vectura creates confusion on both sides

  • Friday, 9 July, 2021
    LexMergers & Acquisitions
    Philip Morris/Vectura: inhale seizer seeks future beyond smoke Premium content

    A danger for the tobacco group is expanding wholesale into industries where similarities with its core business are only superficial

  • Friday, 9 July, 2021
    Mergers & Acquisitions
    Marlboro maker Philip Morris strikes deal for UK inhaler group Vectura

    Tobacco giant gatecrashes agreement with Carlyle in quest to become ‘healthcare and wellness’ group

  • Wednesday, 26 May, 2021
    Mergers & Acquisitions
    Pharma and healthcare in merger buzz as two £1bn deals agreed

    Ramsay Health Care swoops for Spire as private equity’s Carlyle snaps up London-listed Vectura

  • Thursday, 8 November, 2018
    LombardMatthew Vincent
    Sainsbury’s tries to hit right notes to win over Asda deal critics

    Mike Coupe needs to stress how competitive and unprofitable supermarkets can be

  • Thursday, 8 November, 2018
    Hikma Pharmaceuticals PLC
    Hikma and Vectura agree to develop generic rival to asthma drug
  • Thursday, 9 November, 2017
    Pharmaceuticals sector
    Hikma cuts forecasts, key new drug hits fresh FDA barrier
  • Wednesday, 6 September, 2017
    Pharmaceuticals sector
    Vectura shares drop 10% as losses mount
  • Monday, 24 April, 2017
    UK equities
    Vectura slips in caution ahead of key drug approval

    UK stocks follow global rally in response to France’s presidential contest

  • Wednesday, 16 March, 2016
    UK companies
    Pharma merger to create UK champion in respiratory medicines

    Vectura and Skyepharma £441m merger will bolster midsized pharmaceuticals groups

  • Wednesday, 16 March, 2016
    Mergers & Acquisitions
    Vectura and Skyepharma agree £441m merger
  • Tuesday, 19 May, 2015
    UK companies
    Circassia £275m fundraising signals revival of UK biotech sector

    Share placement shows renewed appetite in sector where Shire’s success has been the exception

  • Friday, 9 January, 2015
    Energy sector
    Small-cap Week, January 10

    Vectura, Sirius Minerals, Petroceltic, and WANdisco featured

  • Friday, 11 April, 2014
    Technology sector
    Small-cap Week, April 11
Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In